These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 9329563

  • 1. PSA standardization: a review of NCCLS, Stanford and Abbott efforts.
    Segurado OG, Volmer W, Dowell B.
    Anticancer Res; 1997; 17(4B):2919-20. PubMed ID: 9329563
    [Abstract] [Full Text] [Related]

  • 2. Issues on standardization of immunoassays for prostate-specific antigen: a review.
    Graves HC.
    Clin Invest Med; 1993 Dec; 16(6):415-24. PubMed ID: 7516830
    [Abstract] [Full Text] [Related]

  • 3. [Progress in standardization of total PSA immunoassays].
    Ishibashi M.
    Rinsho Byori; 2004 Jul; 52(7):618-24. PubMed ID: 15344562
    [Abstract] [Full Text] [Related]

  • 4. Issues in the assessment of PSA immunoassays.
    Vessella RL, Lange PH.
    Urol Clin North Am; 1993 Nov; 20(4):607-19. PubMed ID: 7505968
    [Abstract] [Full Text] [Related]

  • 5. Improving the comparability of immunoassays for prostate-specific antigen (PSA): progress and problems.
    Sturgeon CM, Ellis AR.
    Clin Chim Acta; 2007 May; 381(1):85-92. PubMed ID: 17408608
    [Abstract] [Full Text] [Related]

  • 6. Assay standardization bias: different prostate cancer detection rates and clinical outcomes resulting from different assays for free and total prostate-specific antigen.
    Sotelo RJ, Mora KE, Pérez LH, Novoa J, Carmona O, De Andrade R, Borges RE, Parada D, Loeb S, Catalona WJ.
    Urology; 2007 Jun; 69(6):1143-6. PubMed ID: 17572203
    [Abstract] [Full Text] [Related]

  • 7. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum.
    Fernández-Sánchez C, McNeil CJ, Rawson K, Nilsson O, Leung HY, Gnanapragasam V.
    J Immunol Methods; 2005 Dec 20; 307(1-2):1-12. PubMed ID: 16277989
    [Abstract] [Full Text] [Related]

  • 8. [Standardization of PSA assays].
    Kuriyama M.
    Nihon Rinsho; 1998 Aug 20; 56(8):1998-2002. PubMed ID: 9750495
    [Abstract] [Full Text] [Related]

  • 9. [The present status of standardization in serum total PSA measurement--a result of "Survey 2000" conducted by PSA ad hoc Committee of Japanese Urological Association].
    Kano S, Ishibashi M, Itoh Y, PSA ad hoc Committee of Japanese Urological Association.
    Rinsho Byori; 2001 Oct 20; 49(10):967-73. PubMed ID: 11769473
    [Abstract] [Full Text] [Related]

  • 10. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
    Gray MA, Cooke RR, Weinstein P, Nacey JN.
    Ann Clin Biochem; 2004 May 20; 41(Pt 3):207-12. PubMed ID: 15117434
    [Abstract] [Full Text] [Related]

  • 11. Automated Cobas Core PSA assays: sensitive, precise, and specific measurement of PSA-total and PSA-total/PSA-free ratio.
    Groche D, Trebo R, Peters I, Pfleiderer P.
    Anticancer Res; 1999 May 20; 19(4A):2767-70. PubMed ID: 10470238
    [Abstract] [Full Text] [Related]

  • 12. Physicochemical conditions affecting the formation/stability of serum complexes and the determination of prostate-specific antigen (PSA).
    Kioukia-Fougia N, Christofidis I, Strantzalis N.
    Anticancer Res; 1999 May 20; 19(4B):3315-20. PubMed ID: 10652627
    [Abstract] [Full Text] [Related]

  • 13. Purification and characterization of prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin: potential reference material for international standardization of PSA immunoassays.
    Chen Z, Prestigiacomo A, Stamey TA.
    Clin Chem; 1995 Sep 20; 41(9):1273-82. PubMed ID: 7544704
    [Abstract] [Full Text] [Related]

  • 14. Prostate-specific antigen: bias and molarity of commercial assays for PSA in use in England.
    Roddam AW, Rimmer J, Nickerson C, Ward AM, NHS Prostate Cancer Risk Management Programme.
    Ann Clin Biochem; 2006 Jan 20; 43(Pt 1):35-48. PubMed ID: 16390608
    [Abstract] [Full Text] [Related]

  • 15. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R.
    Cancer; 1998 Dec 15; 83(12):2540-7. PubMed ID: 9874461
    [Abstract] [Full Text] [Related]

  • 16. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
    Lein M, Jung K, Elgeti U, Brux B, Sinha P, Schnorr D, Loening SA.
    Anticancer Res; 2000 Dec 15; 20(6D):4997-5001. PubMed ID: 11326657
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relevance of the prostate-specific antigen (PSA) nanotest compared to the classical PSA test in the organized mass screening of prostate cancer.
    Azzouzi AR, Larre S, Cormier L, Roupret M, Valeri A, Mangin P, Berthon P, Villette JM, Fiet J, Cussenot O.
    BJU Int; 2007 Apr 15; 99(4):762-4. PubMed ID: 17233806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.